Genfit (Genfit) Pre-Tax Income : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Genfit Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Genfit's pretax income for the three months ended in Dec. 2023 was $0.00 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Genfit's pretax margin was 0.00%.

During the past 13 years, Genfit's highest Pretax Margin was 86.77%. The lowest was -115760.87%. And the median was -2152.94%.

Genfit Pre-Tax Income Historical Data

The historical data trend for Genfit's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genfit Pre-Tax Income Chart

Genfit Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-73.02

-123.66

78.50

-25.25

-31.10

Genfit Quarterly Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Genfit's Pre-Tax Income

For the Biotechnology subindustry, Genfit's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genfit's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genfit's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Genfit's Pre-Tax Income falls into.

Genfit Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Genfit's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-29.624	+	0.079	+	-5.043	+	1.864	+	1.629
	=	-31.10

Genfit's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	0	+	0	+	0	+	0	+	0
	=	0.00

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Genfit (OTCPK:GNFTF) Pre-Tax Income Explanation

Genfit's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	0	/	15.556
	=	0.00%

During the past 13 years, Genfit's highest Pretax Margin was 86.77%. The lowest was -115760.87%. And the median was -2152.94%.

Genfit Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Genfit's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Genfit (Genfit) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genfit SA (OTCPK:GNFTF) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

GNFT:USA 0QT6:UK GNFT:France XUPB:Germany

Address

Parc Eurasante, 885, Avenue Eugene Avinee, Loos, FRA, 59120

Website

https://www.genfit.com

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.